The FDA’s vaccine advisory panel spent all of yesterday discussing the results of Pfizer and BioNTech’s COVID vaccine studies. At the end of the day, they voted “yes” to the question of whether the available science suggests the benefits of the vaccine outweigh its risks. The FDA is expected to move quickly to grant…
